Attentiondeficit-/hyperactivity disorder in adults;Die aufmerksamkeitsdefizit-/hyperaktivitätsstörung bei erwachsenen

Fortschritte der Neurologie Psychiatrie

Volumn 75, Issue 5, 2007, Pages 293-305

  Krause, Johanna ^a  

^a Psychoanalyse ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPHENIDATE;

ATTENTION DEFICIT DISORDER; COMORBIDITY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIFFERENTIAL DIAGNOSIS; HUMAN; HYPERACTIVITY; PREVALENCE; REVIEW;

ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; DIAGNOSIS, DIFFERENTIAL; HUMANS; PSYCHOANALYTIC THERAPY; PSYCHOTHERAPY;

EID: 34249992640     PISSN: 07204299     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-919081     Document Type: Review

References (26)

1. Murphy KR, Adler LA. Assessing attention-deficit/hyperactivity disorder in adults: focus on rating scales. J Clin Psychiat 2004; 65 (Suppl. 3): 12-17
2. Ebert D, Krause J, Roth-Sackenheim C. ADHS im Erwachsenenalter - Leitlinien auf der Basis eines Expertenkonsensus mit Unterstützung der DGPPN. Nervenarzt 2003; 74: 939-946
3. Krause KH, Krause J, Trott GE. Das hyperkinetische Syndrom (Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung) im Erwachsenenalter. Nervenarzt 1998; 69: 543-556
4. Faraone SV, Biederman J. Neurobiology of attention-deficit hyperactivity disorder. Biol Psychiatry 1998; 44: 951-958
5. Wender PH. Attention-deficit hyperactivity disorder in adults. New York-Oxford: Oxford University Press; 1995
6. Biederman J. Impact of comorbidity in adults with attention-deficit/hyperactivity disorder. J Clin Psychiat 2004; 65 (Suppl. 3): 3-7
7. Faraone SV, Perlis RH, Doyle AE, Smoller JW, Goralnick JJ, Holmgren MA, Sklar P. Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry 2005; 57: 1313-1323
8. Dougherty DD, Bonab AA, Spencer TJ, Rauch SL, Madras BK, Fischman AJ. Dopamine transporter density in patients with attention deficit hyperactivity disorder. Lancet 1999; 354: 2132-2133
9. Krause KH, Dresel SH, Krause J, Kung HF, Tatsch K. Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: effects of methylphenidate as measured by single photon emission computed tomography. Neurosci Lett 2000; 285: 107-110
10. Krause KH, Dresel SH, Krause J, la Fougere C, Ackenheil M. The dopamine transporter and neuroimaging in attention deficit hyperactivity disorder. Neurosci Biobehav Rev 2003; 27: 605-613
11. Spencer TJ, Biederman J, Madras BK, Faraone SV, Dougherty DD, Bonab AA, Fischman AJ. In vivo neuroreceptor imaging in attention-deficit/ hyperactivity disorder: a focus on the dopamine transporter. Biol Psychiatry 2005; 57: 1293-1300
12. Weltgesundheitsorganisation. Internationale Klassifikation psychischer Störungen. ICD-10. Bern: Huber; 1991
13. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4.th edition (DSM IV). Washington DC: American Psychiatric Association; 1994
14. Krause J, Krause KH. ADHS im Erwachsenenalter. Die Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung bei Erwachsenen. 2. Auflage. Stuttgart: Schattauer; 2005
15. Ward MF, Wender PH, Reimherr FW. The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. Am J Psychiatry 1993; 150: 885-890
16. Retz-Junginger P, Retz W, Blocher D, Weijers HG, Trott GE, Wender PH, Rösler M. Wender Utah Rating Scale (WURS-k). Die deutsche Kurzform zur retrospektiven Erfassung des hyperkinetischen Syndroms bei Erwachsenen. Nervenarzt 2002; 73: 830-838
17. Conners CK, Erhardt D, Sparrow E. Conners' Adult ADHD Rating Scales (CAARS). North Tonawanda, NY: Multi-Health Systems; 1999
18. Schöchlin C, Engel RR. Neuropsychological performance in adult attention-deficit hyperactivity disorder: meta-analysis of empirical data. Arch Clin Neuropsychol 2005; 20: 727-744
19. Fone KC, Nutt DJ. Stimulants: use and abuse in the treatment of attention deficit hyperactivity disorder. Curr Opin Pharmacol 2005; 5: 87-93
20. Faraone SV, Spencer T, Aleardi M, Pagano C, Biederman J. Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/hyperactivity disorder. J Clin Psychopharmacol 2004; 24: 24-29
21. Sobanski E, Alm B. Aufmerksamkeitsdefizit-/ Hyperaktivitätsstörung (ADHS) bei Erwachsenen. Nervenarzt 2004; 75: 697-716
22. Weiss MD, Weiss JR. A guide to the treatment of adults with ADHD. J Clin Psychiat 2004; 65 (Suppl. 3): 27-37
23. Wilens TE, Faraone SV, Biederman J, Gunawardene S. Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics 2003; 111: 179-185
24. Krause J, la Fougere C, Krause KH, Ackenheil M, Dresel SH. Influence of striatal dopamine transporter availability on the response to methylphenidate in adult patients with ADHD. Eur Arch Psychiatry Clin Neurosci 2005; 255: 428-431
25. Michelson D, Adler L, Spencer T, Reimherr FW, West SA, Allen AJ, Kelsey D, Wernicke J, Dietrich A, Milton D. Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies. Biol Psychiatry 2003; 53: 112-120
26. Heßlinger B, Philipsen A, Richter H. Psychotherapie der ADHS im Erwachsenenalter. Göttingen: Hogrefe; 2004